company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4919000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4919000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1097000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2076000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-77000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,447000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2523000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2052000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,763000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1986200000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.09
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1986200000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1986200000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.09
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2007.0,FY,2007-01-01,2007-12-31,2010-02-19 15:38:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.15
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12399000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4140000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3544000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4776000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1090000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,2557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,996000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5247000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.62
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,FY,2008-01-01,2008-12-31,2011-02-18 13:34:50+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.24
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1634000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1634000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,834000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1160000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,164000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1155000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,308000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,847000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1990000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2578000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1983100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2014100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.28
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1983100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q3,2008-07-01,2008-09-30,2009-10-22 11:39:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3533000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,420000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,858000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,30000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,963000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1005000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,764000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2010500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2010500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2010500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2008.0,Q2,2008-04-01,2008-06-30,2009-07-23 14:01:55+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5140000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5140000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3946000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3647000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8997000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,550000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,931000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5602000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4420000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7442000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10612000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1983600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1987300000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1983600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,FY,2009-01-01,2009-12-31,2012-02-17 08:44:56+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.25
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5033000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5033000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3600000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,47000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2659000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,264000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,379000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1320000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,8353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,8025000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1983600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1987300000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1983600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q4,2009-10-01,2009-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10068000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2776000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,802000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,89000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6338000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,435000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,117000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4282000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,994000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3509000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2587000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.29
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.25
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3YTD,2009-01-01,2009-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4788000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4788000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,953000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,256000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,820000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2080000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1391000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,139000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,35000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,91000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.48
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q3,2009-07-01,2009-09-30,2010-10-26 10:29:00+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2390000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6597000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1823000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,546000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1719000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,38000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2339000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,82000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,378000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2717000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,628000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.81
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2234100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2YTD,2009-01-01,2009-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.62
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4665000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4665000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1225000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1225000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3440000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,160000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1522000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,315000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,983000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2234100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q2,2009-04-01,2009-06-30,2010-07-22 10:50:12+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4322000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4322000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1165000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3157000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,901000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,248000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,908000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,146000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,72000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,275000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,921000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,283000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1993800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1993800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1993800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2009.0,Q1,2009-01-01,2009-03-31,2010-04-29 10:49:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19484000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19484000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14207000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3566000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5978000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,93000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,93000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6071000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1558000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3102000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.8
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.79
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.8
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,FY,2010-01-01,2010-12-31,2013-02-15 08:55:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.29
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1414000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1414000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1000000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,271000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1010000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2209000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1488000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-252000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-75000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1413000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,571000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,842000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,842000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,359000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q4,2010-10-01,2010-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4798000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4798000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3518000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1984000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1534000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,70000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1614000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,312000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,949000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.55
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3,2010-07-01,2010-09-30,2011-10-27 12:01:45+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3863000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3863000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2686000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,706000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2556000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6020000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4490000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,252000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-84000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1052000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3YTD,2010-01-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.96
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1040000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5431000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,547000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5978000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4803000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7221000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1725500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.62
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q3TTM,2009-10-01,2010-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.28
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4768000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4768000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3491000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,894000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,263000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,822000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2003000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1488000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,85000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1592000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1268000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,341000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,927000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.54
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1749100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.54
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2,2010-04-01,2010-06-30,2011-07-28 10:57:05+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2583000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2583000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6992000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1794000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,35000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2956000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-94000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,88000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3044000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,675000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2369000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2369000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,699000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.97
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1749100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.96
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.97
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2YTD,2010-01-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19396000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19396000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14063000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3917000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1065000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3660000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,133000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,436000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,641000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5929000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7312000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10661000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1749100000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1716700000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q2TTM,2009-07-01,2010-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.27
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4807000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4807000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1306000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1306000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,900000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,910000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2033000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1468000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,358000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,743000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1,2010-01-01,2010-03-31,2011-04-28 11:26:13+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19293000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19293000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5281000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5281000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3945000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,1100000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3649000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,128000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8850000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5162000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,196000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincome,netincomediscontinued,Net Income / (Loss) Discontinued Operations,+,credit,usd,7441000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12042000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1325000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,10717000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.46
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.45
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1727900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.46
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2010.0,Q1TTM,2009-04-01,2010-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.26
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21244000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3839000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8999000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6647000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6981000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1721000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3709000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.18
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.16
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.18
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,FY,2011-01-01,2011-12-31,2014-02-14 09:37:38+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1832000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4087000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1216000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,285000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1008000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-92000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2417000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,139000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-76000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1594000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,363000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,379000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.5
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.5
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q4,2011-10-01,2011-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15790000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15790000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4231000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11559000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,672000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2831000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,92000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6582000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4977000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,410000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5387000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1358000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.68
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.68
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3YTD,2011-01-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.99
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20901000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20901000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5645000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5645000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15256000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,943000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3841000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,otherspecialcharges,Other Special Charges / (Income),+,debit,usd,-22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8791000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6465000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-37000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,372000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6800000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1929000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1531000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3340000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.96
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.96
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3TTM,2010-10-01,2011-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,973000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1733000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,71000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,475000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,386000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q3,2011-07-01,2011-09-30,2012-10-24 11:06:28+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1481000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3953000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1040000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,253000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,923000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingexpenses,otheroperatingexpenses,Other Operating Expenses / (Income),+,debit,usd,0.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,40000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2256000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,62000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,31000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,93000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1790000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,483000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,405000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,902000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1734600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2,2011-04-01,2011-06-30,2012-07-25 11:24:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10445000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10445000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1968000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,467000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1858000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,84000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4377000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3244000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,169000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,313000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3557000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,883000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,786000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1888000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1734600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2YTD,2011-01-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.66
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20354000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20354000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5518000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5518000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,49000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8570000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6266000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-38000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,356000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,318000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1498000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3320000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.94
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1734600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.92
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1701900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.94
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q2TTM,2010-07-01,2011-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.31
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19688000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19688000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5314000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5314000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14374000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3714000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3591000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,33000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6057000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-15000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6386000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1607000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1434000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1TTM,2010-04-01,2011-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1343000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1343000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,928000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,214000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,935000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1547000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,82000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,138000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1767000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,400000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,986000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.58
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1702000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.58
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2011.0,Q1,2011-01-01,2011-03-31,2012-04-26 11:49:15+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3967000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4191000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1075000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1075000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3116000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1143000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-166000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-166000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,924000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,924000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,925000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q4,2012-10-01,2012-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13654000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3967000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,797000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3904000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10751000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2340000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,541000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1960000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.17
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.17
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,FY,2012-01-01,2012-12-31,2015-02-13 09:38:42+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3736000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3736000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2749000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1071000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1259000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-546000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-711000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3,2012-07-01,2012-09-30,2013-10-23 10:50:53+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13430000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13430000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9895000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,585000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2822000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8314000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1581000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,246000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,542000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1035000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.6
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.6
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3YTD,2012-01-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.02
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15262000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18884000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4902000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4902000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13982000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4293000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-92000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10731000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,385000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,170000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,613000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,921000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1887000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1666000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q3TTM,2011-10-01,2012-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.36
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4443000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4443000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1245000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1245000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,962000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2190000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1008000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1059000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,645000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2,2012-04-01,2012-06-30,2013-07-25 11:31:51+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9694000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9694000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2548000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2548000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7146000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,418000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2851000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,235000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,235000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3086000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2290000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,544000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1746000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.02
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2YTD,2012-01-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.68
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20493000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5322000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5322000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,908000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-84000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8917000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,400000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,256000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1634000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3567000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.09
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1683000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.1
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q2TTM,2011-07-01,2012-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1303000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1303000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3948000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,909000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2105000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1843000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,184000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,184000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1482000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.65
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.65
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1,2012-01-01,2012-03-31,2013-04-25 11:28:06+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3622000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21484000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5558000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5558000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15926000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,937000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3813000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,-44000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8983000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6943000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,-82000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,380000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7241000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1866000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5375000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.25
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.23
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.25
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2012.0,Q1TTM,2011-04-01,2012-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4081000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16385000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4619000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4939000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3731000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3096000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-205000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2891000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.54
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,FY,2013-01-01,2013-12-31,2016-02-12 08:02:37+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.41
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1143000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4441000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1923000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2279000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,889000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,869000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,134000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,735000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,735000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,726000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q4,2013-10-01,2013-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3346000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3346000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8598000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3016000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2774000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6391000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2207000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-185000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-185000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2022000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.12
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.12
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3YTD,2013-01-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9230000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,6905000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11714000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,813000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8828000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2886000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-351000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2535000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-234000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2769000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2762000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.69
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.68
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.69
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3TTM,2012-10-01,2013-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3025000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1040000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4065000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2890000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,893000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2067000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,823000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,818000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,126000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q3,2013-07-01,2013-09-30,2014-10-24 11:16:25+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5981000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7879000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1881000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4324000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1384000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1204000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1153000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,8000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1145000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2YTD,2013-01-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9941000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,5865000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15806000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4233000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11573000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,786000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3914000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10780000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,793000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-906000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1364000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1359000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.84
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.84
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2TTM,2012-07-01,2013-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1024000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4048000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2940000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1042000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,729000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,530000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,536000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.32
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.33
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q2,2013-04-01,2013-06-30,2014-07-24 11:18:20+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11360000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4841000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4370000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4370000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11831000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,792000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3925000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,1830000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10759000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1072000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-85000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-85000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1642000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1642000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,174000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1468000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.89
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.89
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.89
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1TTM,2012-04-01,2013-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,874000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3831000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1063000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1063000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2768000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,994000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,189000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,930000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2113000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,19000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2013.0,Q1,2013-01-01,2013-03-31,2014-04-29 09:49:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11660000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15879000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3932000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3932000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4822000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4534000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9356000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2591000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-210000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-210000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,352000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,FY,2014-01-01,2014-12-31,2017-02-21 12:04:14+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.45
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3240000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1018000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1885000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1189000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2553000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,739000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-799000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-799000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-60000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-87000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,14000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q4,2014-10-01,2014-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2843000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3921000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1007000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1007000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2914000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,983000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2183000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,731000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,277000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1008000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,276000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,732000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,721000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3,2014-07-01,2014-09-30,2015-10-27 12:36:09+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8420000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3201000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2937000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3345000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6803000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1852000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,589000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2441000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2002000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1991000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.19
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3YTD,2014-01-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.08
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11718000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16062000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11823000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-80000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4302000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2741000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3310000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,573000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2737000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2717000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.62
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1658000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q3TTM,2013-10-01,2014-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.44
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1119000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3889000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,991000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,991000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1416000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2554000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2,2014-04-01,2014-06-30,2015-07-23 11:35:16+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2123000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7700000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1959000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1959000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5741000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1908000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,350000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4620000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,312000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,312000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.77
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.77
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2YTD,2014-01-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11900000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4306000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11799000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2833000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3120000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,423000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2697000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2688000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1657000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q2TTM,2013-07-01,2014-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.43
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2807000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,968000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,968000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2843000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,946000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2066000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,777000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,208000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,985000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,937000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1,2014-01-01,2014-03-31,2015-04-28 07:36:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.36
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16365000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4524000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11841000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4902000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-26000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3747000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8623000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3218000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2893000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2893000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2891000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.73
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1652000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2014.0,Q1TTM,2013-04-01,2014-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14045000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16560000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3909000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3909000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12651000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4841000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10761000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1890000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2077000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,446000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1565000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.94
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.94
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,FY,2015-01-01,2015-12-31,2018-02-13 09:26:31+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.49
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,425000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4287000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,952000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,952000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1501000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1916000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3417000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-82000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-410000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-222000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-197000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q4,2015-10-01,2015-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,517000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4069000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1097000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1097000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2972000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1176000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1132000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2308000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,323000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,323000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,987000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,257000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,730000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,706000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3,2015-07-01,2015-09-30,2016-10-27 11:35:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10183000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,2090000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2957000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3340000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1972000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2487000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,57000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1762000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3YTD,2015-01-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.11
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13423000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3108000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16531000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3923000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3923000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12608000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5225000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-521000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9897000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2711000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-284000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-284000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,581000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1846000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1846000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,71000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.06
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1668000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.06
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q3TTM,2014-10-01,2015-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.48
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3572000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,591000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1013000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3150000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2991000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,159000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-107000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,52000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,162000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-110000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,20000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-130000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.08
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.08
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.08
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2,2015-04-01,2015-06-30,2016-07-28 11:32:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1573000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8204000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1860000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2164000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2872000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1308000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,192000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1500000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1089000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1056000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2YTD,2015-01-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.74
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12714000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,3669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16383000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3833000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3833000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12550000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-350000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5044000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9772000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2778000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-330000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,600000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1848000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1848000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1790000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.07
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.07
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1667000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.07
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q2TTM,2014-07-01,2015-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.47
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3059000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,982000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4041000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,847000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,847000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3194000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1029000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1016000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2045000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1149000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,299000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,299000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,249000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1199000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1186000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1,2015-01-01,2015-03-31,2016-04-28 11:32:42+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.37
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,4197000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16109000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3811000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12298000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4894000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,marketingexpense,Marketing Expense,+,debit,usd,-163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4604000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2963000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-119000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-119000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2844000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,552000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2292000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,39000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2253000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1663000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2015.0,Q1TTM,2014-04-01,2015-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.46
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5012000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9991000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4467000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5915000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1408000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4507000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,50000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4457000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.67
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.65
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.67
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,FY,2016-01-01,2016-12-31,2019-02-25 16:52:22+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6539000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5243000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3837000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1529000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1472000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3001000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1086000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,898000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,894000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.53
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q4,2016-10-01,2016-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4492000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,430000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1305000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1305000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3617000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1138000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2282000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1559000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,344000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3,2016-07-01,2016-09-30,2017-10-26 11:27:47+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12888000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14184000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10621000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3450000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3540000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6990000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3631000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1198000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4829000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1220000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,46000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.12
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3YTD,2016-01-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16750000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1721000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13956000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5456000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10407000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4419000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,998000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3421000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,55000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1671000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q3TTM,2015-10-01,2016-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4432000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3665000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1266000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2504000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,454000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1615000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,22000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1166000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.69
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2,2016-04-01,2016-06-30,2017-07-27 11:23:30+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8396000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,866000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9262000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2258000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7004000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2306000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2402000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4708000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,974000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,974000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3270000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2394000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,33000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2361000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2YTD,2016-01-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15810000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1808000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17618000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4307000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13311000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4983000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5450000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2878000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,969000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3847000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,911000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,66000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2870000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.73
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.7
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1670000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.73
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q2TTM,2015-07-01,2016-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3964000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4391000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1052000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1052000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3339000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1068000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1136000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2204000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,449000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1206000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1195000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.72
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1,2016-01-01,2016-03-31,2017-04-27 11:29:01+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14950000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1960000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16910000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4880000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6040000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1876000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,408000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,408000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2284000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1638000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,64000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1669000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2016.0,Q1TTM,2015-04-01,2016-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.5
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20776000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20776000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6014000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6014000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14762000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4751000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6468000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3446000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5131000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4156000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-32000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1007000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,FY,2017-01-01,2017-12-31,2020-02-24 16:10:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6564000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5449000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3848000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1316000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1925000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3338000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,510000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,188000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,698000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3027000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-2329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-2329000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-1000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-2328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1650800000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.42
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q4,2017-10-01,2017-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.17
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4862000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,392000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3675000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2724000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,951000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,232000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1183000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,327000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,856000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,845000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.52
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3,2017-07-01,2017-09-30,2018-10-25 11:36:04+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14212000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,1115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15327000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4413000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4413000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10914000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3435000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4543000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7978000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,2936000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1497000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1497000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4433000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-31000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3335000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3YTD,2017-01-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.17
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20751000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-181000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20570000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5819000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14751000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4964000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6015000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3772000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1747000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1747000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5519000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1317000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4202000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4229000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.54
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1639000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q3TTM,2016-10-01,2017-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4770000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,374000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1569000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3575000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1187000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2866000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,709000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,586000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,586000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1295000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,922000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,6000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,916000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.56
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2,2017-04-01,2017-06-30,2018-07-26 11:32:21+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9350000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,723000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10073000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2834000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2834000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7239000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2272000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2982000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5254000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1985000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,802000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,2448000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-42000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,2490000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.5
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.51
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2YTD,2017-01-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.78
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20381000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-143000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,20238000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5545000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14693000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4945000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5592000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10537000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4156000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1739000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1739000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5895000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1334000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4586000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.75
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1644000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q2TTM,2016-07-01,2017-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.55
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4580000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,349000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4929000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1265000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3664000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1085000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1303000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2388000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1276000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,679000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1955000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,429000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1526000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-48000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.94
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.95
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1,2017-01-01,2017-03-31,2018-04-26 12:08:19+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,20043000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-78000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19965000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5182000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14783000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4996000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5179000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10175000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4608000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1607000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1607000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1388000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4827000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4836000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.9
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.88
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.9
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2017.0,Q1TTM,2016-04-01,2017-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.54
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22561000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6467000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6467000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16094000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6332000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5114000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,854000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,854000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5968000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1021000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4947000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,27000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,FY,2018-01-01,2018-12-31,2020-02-24 16:10:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.61
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5973000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5973000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4363000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1336000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1367000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2800000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1563000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-58000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1505000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,347000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-2000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1160000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1634600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.71
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q4,2018-10-01,2018-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-1.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5691000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5691000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1648000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1648000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4043000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1280000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2384000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1659000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,508000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,508000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,255000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,11000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1901000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.16
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.16
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3,2018-07-01,2018-09-30,2019-10-31 09:39:45+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,16588000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,16588000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,4857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,4857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11731000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3215000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4965000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,8180000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3551000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,912000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4463000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,674000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3789000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,29000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3760000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.3
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3YTD,2018-01-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.2
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23152000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-1115000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,22037000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6458000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15579000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4531000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6890000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11518000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,4061000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1100000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1100000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5161000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3701000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1432000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.9
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q3TTM,2017-10-01,2018-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.03
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5704000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5704000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1625000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1625000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4079000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1131000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2435000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,3566000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,513000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,517000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,373000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2,2018-04-01,2018-06-30,2019-07-25 11:33:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10897000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10897000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3209000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3209000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7688000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,3685000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,5796000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1892000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2296000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,419000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1877000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1877000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,18000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2YTD,2018-01-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.8
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,22323000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-723000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21600000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15211000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4590000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7171000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11858000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4177000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3773000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,28000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,376000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.24
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.25
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.24
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q2TTM,2017-07-01,2018-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.02
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,980000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1250000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2230000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1379000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,400000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,400000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1779000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,284000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1486000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.91
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.91
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.91
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1,2018-01-01,2018-03-31,2019-04-25 11:39:35+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,21389000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,otherrevenue,Other Revenue,+,credit,usd,-349000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,21040000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6333000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4646000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6415000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,97000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11158000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3549000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1406000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4955000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4011000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,944000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,919000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1633000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.57
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2018.0,Q1TTM,2017-04-01,2018-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7945000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7945000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,2452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,2452000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5493000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1734000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2090000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1111000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4935000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,558000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-687000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-129000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,931000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1060000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-4000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1056000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1702500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.74
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1710900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.73
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1702500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.74
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q4,2019-10-01,2019-12-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.82
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26145000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26145000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,8078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,8078000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18067000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4871000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6148000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,1135000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5913000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-938000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,4975000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1515000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3460000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1702500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.02
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1710900000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.01
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1702500000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.02
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,FY,2019-01-01,2019-12-31,2020-02-24 16:10:27+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,1.68
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18200000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18200000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,5626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,5626000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12574000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3137000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,4058000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7219000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5355000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-251000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,5104000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,584000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4520000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4495000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.74
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.76
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3YTD,2019-01-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.82
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,24173000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,24173000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7236000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16937000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4473000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5425000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10019000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6918000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-309000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6609000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,931000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5678000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5655000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.47
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.45
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.47
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3TTM,2018-10-01,2019-09-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.38
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6007000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6007000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1810000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1810000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4197000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1055000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1382000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2437000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1760000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-411000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1349000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-17000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1366000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,13000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1353000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.83
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.83
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1632000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.83
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q3,2019-07-01,2019-09-30,2019-10-31 09:39:45+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.41
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12193000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3816000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3816000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8377000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2082000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2676000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,4782000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3595000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,160000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,160000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3755000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,601000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3154000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,12000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3142000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.91
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.93
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2YTD,2019-01-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.41
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23857000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,7074000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,7074000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16783000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4522000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5323000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9966000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,6817000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,610000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,7427000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6224000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6203000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.8
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.78
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.8
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2TTM,2018-07-01,2019-06-30,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.39
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6273000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1992000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1992000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4281000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1076000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1328000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2404000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1877000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-101000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1776000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,337000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1439000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,7000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1432000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1636000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q2,2019-04-01,2019-06-30,2019-07-25 11:33:59+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.41
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5920000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1824000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4096000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,1348000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,24000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,2378000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,1718000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,261000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,261000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,264000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,5000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1710000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1628600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644200000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.04
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1628600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 09:54:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.05
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,23288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,23288000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,6707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,6707000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,16581000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4577000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6430000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,121000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11128000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5453000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,715000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,6168000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1001000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5167000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,23000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5144000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,1628600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.15
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,1644200000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.14
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,1628600000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.15
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2019.0,Q1TTM,2018-04-01,2019-03-31,,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,-0.4
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,31006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,31006000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,9916000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,9916000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,21090000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5471000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7172000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,3393000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16036000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,5054000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2362000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2692000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1713000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,979000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,25000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,954000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10781000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10781000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,3662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,3662000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7119000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1606000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,2372000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totaloperatingexpenses,amortizationexpense,Amortization Expense,+,debit,usd,2282000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,6260000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,859000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1163000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-304000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,462000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-766000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,9000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-775000000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,2279400000.0
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
Bristol-Myers Squibb Co,BMY,HLYYNH7UQUORYSJQCN42,0000014272,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 09:54:07+00:00,,cashdividendspershare,Cash Dividends to Common per Share,=,,usdpershare,0.45
